Loading…
High expression of NFX1‐123 in HPV positive head and neck squamous cell carcinomas
Background High‐risk human papillomaviruses (HR HPV) cause nearly all cervical cancers and, in the United States, the majority of head and neck cancers (HNSCCs). NFX1‐123 is overexpressed in cervical cancers, and NFX1‐123 partners with the HR HPV type 16 E6 oncoprotein to affect multiple growth, dif...
Saved in:
Published in: | Head & neck 2022-01, Vol.44 (1), p.177-188 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
High‐risk human papillomaviruses (HR HPV) cause nearly all cervical cancers and, in the United States, the majority of head and neck cancers (HNSCCs). NFX1‐123 is overexpressed in cervical cancers, and NFX1‐123 partners with the HR HPV type 16 E6 oncoprotein to affect multiple growth, differentiation, and immune response genes. However, neither the expression of NFX1‐123 nor the levels of these genes have been investigated in HPV positive (HPV+) or negative (HPV−) HNSCCs.
Methods
The Cancer Genome Atlas Splicing Variants Database and HNSCC cell lines were used to quantify expression of NFX1‐123 and cellular genes increased in cervical cancers.
Results
NFX1‐123 was increased in HPV+ HNSCCs compared to HPV− HNSCCs. LCE1B, KRT16, SPRR2G, and FBN2 were highly expressed in HNSCCs compared to normal tissues. Notch1 and CCNB1IP1 had greater expression in HPV+ HNSCCs compared to HPV− HNSCCs.
Conclusion
NFX1‐123 and a subset of its known targets were increased in HPV+ HNSCCs. |
---|---|
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/hed.26906 |